A growing body of evidence has demonstrated a link between Alzheimer disease (AD) and
epilepsy. Late-onset epilepsy and epileptiform activity can precede cognitive deterioration in …

Alzheimer's disease (AD) is the most common neurological disease, which is associated
with gradual memory loss and correlated with synaptic hyperactivity and abnormal …

An early disruption of neuronal excitation–inhibition (E–I) balance in preclinical animal
models of Alzheimer's disease (AD) has been frequently reported, but is difficult to measure …

Objective Neuronal excitation/inhibition (E/I) imbalance is a potential cause of neuronal
network malfunctioning in Alzheimer's disease (AD), contributing to cognitive dysfunction …

Both sleep alterations and epileptiform activity are associated with the accumulation of
amyloid-β and tau pathology and are currently investigated for potential therapeutic …

Network hyperexcitability (NH) is an important feature of the pathophysiology of Alzheimer's
disease. Functional connectivity (FC) of brain networks has been proposed as a potential …

Alzheimer's disease and epilepsy are common nervous system diseases in older adults, and
their incidence rates tend to increase with age. Patients with mild cognitive impairment and …

Hyperexcitability is a recently recognized contributor to the pathophysiology of Alzheimer's
disease (AD). Subclinical epileptiform activity (SEA) is a neurophysiological sign of cortical …

Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) stand as the prevailing
sources of neurodegenerative dementia, impacting over 55 million individuals across the …

Background: Alzheimer's disease (AD) and epilepsy represent two complex neurological
disorders with distinct clinical manifestations, yet recent research has highlighted their …